Literature DB >> 31419139

Cysteine Residue Containing Merocytochalasans and 17,18-seco-Aspochalasins from Aspergillus micronesiensis.

Zhaodi Wu1, Xiaotian Zhang1, Weaam Hasan Al Anbari1, Qun Zhou1, Peng Zhou1, Mi Zhang1, Fanrong Zeng1, Chunmei Chen1, Qingyi Tong1, Jianping Wang1, Hucheng Zhu1, Yonghui Zhang1.   

Abstract

Two cysteine residue containing merocytochalasans (cyschalasins A and B, 1 and 2) and two 17,18-seco-aspochalasins (secochalasins A and B, 3 and 4) were isolated from the endophytic fungus Aspergillus micronesiensis. Cyschalasins A and B represent a new type of merocytochalasan featuring the fusion of an aspochalasin with a modified cysteine residue. Secochalasins A and B are the first 17,18-seco-aspochalasins to be reported and represent a previously undescribed carbon skeleton. Plausible biosynthetic pathways of 1-4 were proposed. Compounds 1 and 2 were cytotoxic and active against Gram-positive bacteria.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31419139     DOI: 10.1021/acs.jnatprod.9b00016

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

1.  Progress in the Chemistry of Cytochalasans.

Authors:  Hucheng Zhu; Chunmei Chen; Qingyi Tong; Yuan Zhou; Ying Ye; Lianghu Gu; Yonghui Zhang
Journal:  Prog Chem Org Nat Prod       Date:  2021

Review 2.  Fungal Endophytes: A Potential Source of Antibacterial Compounds.

Authors:  Sunil K Deshmukh; Laurent Dufossé; Hemraj Chhipa; Sanjai Saxena; Girish B Mahajan; Manish Kumar Gupta
Journal:  J Fungi (Basel)       Date:  2022-02-08

Review 3.  Sulfur-Containing Compounds from Endophytic Fungi: Sources, Structures and Bioactivities.

Authors:  Yaqin Fan; Zhiheng Ma; Yan Zhang; Yufei Wang; Yousong Ding; Cong Wang; Shugeng Cao
Journal:  J Fungi (Basel)       Date:  2022-06-13

4.  Natural product diversity from the endophytic fungi of the genus Aspergillus.

Authors:  Seham S El-Hawary; Abeer S Moawad; Hebatallah S Bahr; Usama Ramadan Abdelmohsen; Rabab Mohammed
Journal:  RSC Adv       Date:  2020-06-09       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.